BCTX Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	161 625
Średni wolumen	77 820.00
Kapitalizacja rynkowa	22.21M
EPS	$0 ( 2024-03-20 )
Następna data zysków	( $-0.200 ) 2024-06-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.760
ATR14	$0.0150 (1.08%)

Insider Trading

Date	Person	Action	Amount	type
2022-12-28	Bondarenko Jamieson	Buy	28 000	Common Shares
2022-12-23	Williams William V.	Buy	2 530	Warrant
2022-12-20	Bondarenko Jamieson	Buy	22 000	Common Shares
2022-08-01	Bondarenko Jamieson	Sell	0	Common Shares
2021-03-29	Bondarenko Jamieson	Sell	150 000	Option (Right to Buy)

INSIDER POWER
-65.20
Last 25 transactions
Buy: 52 530 \| Sell: 1 209 572

Wolumen Korelacja

Długi: 0.04 (neutral)

Krótki: -0.16 (neutral)

Signal:(50.275) Neutral

BriaCell Therapeutics Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BriaCell Therapeutics Korelacja - Waluta/Towar

0.14
( neutral )

-0.41
( neutral )

0.00
( neutral )

0.47
( neutral )

-0.33
( neutral )

BriaCell Therapeutics Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-15 529.00 (0.00 %)
EPS:	$-1.300

FY	2023
Przychody:	$0
Zysk brutto:	$-15 529.00 (0.00 %)
EPS:	$-1.300

FY	2022
Przychody:	$0
Zysk brutto:	$-15 141.00 (0.00 %)
EPS:	$-0.750

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.0900

Financial Reports:

No articles found.

BriaCell Therapeutics Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

BriaCell Therapeutics

BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.